Plain-English translation of NCT07276724 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new medication called to see if it can help people whose severe asthma is not well controlled, even with strong current treatments. You would receive either the new medication or a placebo (inactive treatment) as an injection under the skin every 6 months for one year. The research team will carefully track how well this treatment works and whether it is safe.
Some people with severe asthma continue to have breakthrough attacks and symptoms even when taking the strongest available medications. This trial exists to find out whether this new treatment can provide better control for patients who haven't had success with current options.
You likely qualify if…
You likely don't qualify if…
You would visit the research clinic several times over about 14 months. After an initial screening period where the team confirms you qualify, you would receive either the new medication or placebo as an injection under your skin at the start of the study and again 6 months later. Throughout the trial, you would have check-in visits, lung function tests, and other assessments to track how you're doing. After the main study ends, you would have the option to continue receiving the actual medication for an additional 3 months.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States